Alcon Inc (ALC)
79.57
+1.15
(+1.47%)
USD |
NYSE |
May 03, 16:00
79.57
0.00 (0.00%)
After-Hours: 20:00
Alcon 1 Year Total Returns (Daily): 8.69% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 8.69% |
| May 02, 2024 | 9.88% |
| May 01, 2024 | 9.39% |
| April 30, 2024 | 7.35% |
| April 29, 2024 | 8.93% |
| April 26, 2024 | 10.64% |
| April 25, 2024 | 9.94% |
| April 24, 2024 | 8.89% |
| April 23, 2024 | 10.98% |
| April 22, 2024 | 10.78% |
| April 19, 2024 | 13.02% |
| April 18, 2024 | 10.67% |
| April 17, 2024 | 12.02% |
| April 16, 2024 | 11.12% |
| April 15, 2024 | 13.19% |
| April 12, 2024 | 15.58% |
| April 11, 2024 | 18.47% |
| April 10, 2024 | 19.19% |
| April 09, 2024 | 17.74% |
| April 08, 2024 | 19.37% |
| April 05, 2024 | 22.78% |
| April 04, 2024 | 20.20% |
| April 03, 2024 | 21.49% |
| April 02, 2024 | 16.16% |
| April 01, 2024 | 16.61% |
| Date | Value |
|---|---|
| March 28, 2024 | 23.50% |
| March 27, 2024 | 22.27% |
| March 26, 2024 | 22.79% |
| March 25, 2024 | 23.30% |
| March 22, 2024 | 25.78% |
| March 21, 2024 | 24.75% |
| March 20, 2024 | 28.69% |
| March 19, 2024 | 29.94% |
| March 18, 2024 | 29.02% |
| March 15, 2024 | 30.74% |
| March 14, 2024 | 31.14% |
| March 13, 2024 | 35.14% |
| March 12, 2024 | 37.12% |
| March 11, 2024 | 37.15% |
| March 08, 2024 | 32.13% |
| March 07, 2024 | 32.24% |
| March 06, 2024 | 25.38% |
| March 05, 2024 | 24.72% |
| March 04, 2024 | 26.06% |
| March 01, 2024 | 28.01% |
| February 29, 2024 | 24.26% |
| February 28, 2024 | 25.94% |
| February 27, 2024 | 15.18% |
| February 26, 2024 | 13.75% |
| February 23, 2024 | 11.21% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-34.33%
Minimum
Nov 03 2022
73.11%
Maximum
Mar 23 2021
9.51%
Average
8.76%
Median
1 Year Total Returns (Daily) Benchmarks
| AC Immune SA | 29.19% |
| CRISPR Therapeutics AG | 13.62% |
| Addex Therapeutics Ltd | -38.14% |
| NLS Pharmaceutics Ltd | -89.70% |
| Molecular Partners AG | -41.47% |